The Recall Desk
SevereFDA (Drugs)·D-1138-2018·Announced 2018-09-05

Torrent Pharma Recalls Amlodipine and Valsartan Tablets Due to Impurity

Torrent Pharma Inc. is recalling Amlodipine and Valsartan Tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the source text explicitly identifies a carcinogen impurity, which constitutes a significant health hazard warranting a Severe rating under the rubric.

Plain-English summary

Torrent Pharma Inc. is recalling Amlodipine and Valsartan Tablets, USP, 5 mg/320 mg, 30 tablets per bottle. The product is identified by NDC 13668-205-30 and was manufactured by Torrent Pharmaceuticals LTD. in India.

The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations, specifically the detection of a carcinogen impurity in the active pharmaceutical ingredient (API) used to manufacture the drug product.

The affected product was distributed nationwide in the United States. Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on alternative treatment options.

The recalled product

Product
Amlodipine and Valsartan Tablets, USP, 5 mg/320 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-205-30
Manufacturer
Torrent Pharma Inc.
Category
Drug — Prescription Medication
Hazard
Affected units
66,864

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (14)

  • Batch: BV84D010
  • BV84E001
  • BV84C011
  • BV84D001
  • BV84D002
  • BV84D005
  • BV84D006
  • BV84D007
  • BV84D008
  • BV84D009
  • BV84C006
  • BV84C007
  • BV84C008
  • BV84C009

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 12 recalled by Torrent Pharma Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 12 products in this recall →

Related recalls

Same manufacturer · Torrent Pharma Inc.

See all →

Same hazard · carcinogen impurity

See all →